CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-09 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −25,840 | $69.04 | $1.8M | 445,333 |
| 2020-11-09 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −17,665 | $69.86 | $1.2M | 427,668 |
| 2020-11-09 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −43,505 | 0 | ||
| 2020-10-23 | Anzalone Christopher Richard Chief Executive Officer | Sale | −87,728 | $58.16 | $5.1M | 2,517,509 |
| 2020-10-23 | Anzalone Christopher Richard Chief Executive Officer | Sale | −12,272 | $58.57 | $719K | 2,505,237 |
| 2020-10-20 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +29,166 | $6.15 | $179K | 456,834 |
| 2020-10-20 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −29,166 | $54.04 | $1.6M | 427,668 |
| 2020-10-20 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −29,166 | 43,505 | ||
| 2020-10-09 | Ferrari Mauro Director | Sale | −10,000 | $48.00 | $480K | 30,971 |
| 2020-10-08 | De Backer Marianne Director | Purchase | +500 | $50.93 | $25K | 17,000 |
| 2020-10-08 | De Backer Marianne Director | Purchase | +500 | $50.00 | $25K | 17,500 |
| 2020-08-13 | Anzalone Christopher Richard Chief Executive Officer | Option exercise | +50,000 | $9.90 | $495K | 2,655,237 |
| 2020-08-13 | Anzalone Christopher Richard Chief Executive Officer | Sale | −50,000 | $41.35 | $2.1M | 2,605,237 |
| 2020-08-13 | Anzalone Christopher Richard Chief Executive Officer | Option exercise · Stock Option (right to buy) | −50,000 | 895,543 | ||
| 2020-06-25 | Anzalone Christopher Richard Chief Executive Officer | Sale | −99,977 | $38.81 | $3.9M | 2,605,260 |
| 2020-06-25 | Anzalone Christopher Richard Chief Executive Officer | Sale | −23 | $39.55 | $910 | 2,605,237 |
| 2020-06-15 | De Backer Marianne Director | Purchase | +500 | $31.33 | $16K | 16,500 |
| 2020-05-14 | PERRY MICHAEL S Director | Option exercise | +7,000 | $4.75 | $33K | 15,000 |
| 2020-05-14 | PERRY MICHAEL S Director | Option exercise | +5,000 | $2.01 | $10K | 20,000 |
| 2020-05-14 | PERRY MICHAEL S Director | Option exercise | +15,000 | $2.19 | $33K | 35,000 |
Page 22 of 38 · 752 trades